Gainers
Audacy, Inc. (NYSE: AUD) gained 75.8% to $0.2337 in pre-market trading after gaining around 16% on Wednesday. The company posted upbeat quarterly sales.
Gainers
TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Gainers
Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in patients undergoing elective surgery.